Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer

Documenti analoghi

• Low thyroid function is associated with metabolic dysfunction‐associated steatotic liver disease
  di: Shuo Wang, et al.
  Pubblicazione: (2024)
• Usefulness of health checkup‐based indices in identifying metabolic dysfunction‐associated steatotic liver disease
  di: Takao Miwa, et al.
  Pubblicazione: (2024)
• Impact of pemafibrate in patients with metabolic dysfunction‐associated steatotic liver disease complicated by dyslipidemia: A single‐arm prospective study
  di: Hiroki Ono, et al.
  Pubblicazione: (2024)
• Dietary characteristics associated with the risk of non‐alcoholic fatty liver disease and metabolic dysfunction‐associated steatotic liver disease in non‐obese Japanese participants: A cross‐sectional study
  di: Hirokazu Taniguchi, et al.
  Pubblicazione: (2024)
• Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research
  di: Yu‐Ming Cheng, et al.
  Pubblicazione: (2024)